Abstract Details
|
Douglas W. Scharre, MD, FAAN
(Ohio State University)
PRESENTER |
Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BrainTest, Inc. Dr. Scharre has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Vascular Scientific. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Acadia. Dr. Scharre has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Scharre has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Hickman & Lowder Co.. The institution of Dr. Scharre has received research support from InSightec. The institution of Dr. Scharre has received research support from Alzheimer's Therapeutic Research Institute (ATRI). The institution of Dr. Scharre has received research support from Eisai. The institution of Dr. Scharre has received research support from vTv Therapeutics. The institution of Dr. Scharre has received research support from National Institute of Health. The institution of Dr. Scharre has received research support from Eli Lilly. The institution of Dr. Scharre has received research support from Johns Hopkins. The institution of Dr. Scharre has received research support from Biogen. The institution of Dr. Scharre has received research support from Roche. The institution of Dr. Scharre has received research support from AZ Therapies. The institution of Dr. Scharre has received research support from Biohaven. The institution of Dr. Scharre has received research support from Novartis. The institution of Dr. Scharre has received research support from Avanir. The institution of Dr. Scharre has received research support from PrecisionMed, Inc. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. Dr. Scharre has received intellectual property interests from a discovery or technology relating to health care. |
| Adriano Chio, MD, FAAN (Dept. of Neuroscience, University of Turin) | Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Chio has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. |
| Shu-Ing Chang (The Ohio State University) | No disclosure on file |
| No disclosure on file | |
| Ariane Park, MD, MPH (Wexner Medical Center At The Ohio State University) | An immediate family member of Dr. Park has stock in LucidHealth. The institution of Dr. Park has received research support from Parkinson Foundation. The institution of Dr. Park has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Park has received research support from Rho, Inc. The institution of Dr. Park has received research support from Cerevel Therapeutics. The institution of Dr. Park has received research support from Addex Therapeutics. |
| Punit Agrawal, DO (The Ohio State University Wexner Medical Center - OSU P) | No disclosure on file |
| Anahita Adeli, MD | No disclosure on file |
| Shannon L. Linder (Ohio State University, Wexner Medical Center) | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Maria Kataki, MD, PhD, FAAN (Albany Medical College, Albany NY) | No disclosure on file |